BofA/Merrill Lynch Downgrades Rockwell Medical Technologies (RMTI) to Underperform

November 8, 2016 7:09 AM EST
Get Alerts RMTI Hot Sheet
Price: $8.06 +5.50%

Rating Summary:
    7 Buy, 2 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade RMTI Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

BofA/Merrill Lynch downgraded Rockwell Medical Technologies (NASDAQ: RMTI) from Neutral to Underperform with a price target of $5.00.

For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.

Shares of Rockwell Medical Technologies closed at $5.66 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment